Search results
Retail investors chant buy-buy amid FPIs’ buy & bye - Times of India
The Times of India· 15 hours agoA steady rise in investments by individuals, especially through mutual funds, has fed the bull rally...
International equity funds perform better than benchmarks but lag domestic returns
CNBC Awaaz· 3 days agoInternational equity funds, which gained huge popularity during the pandemic phase as an increasing...
Indian government bonds join JP Morgan EM Bond Index - What is JP Morgan Emerging Market Bond Index...
The Economic Times· 5 days agoWhat is JP Morgan Emerging Market Bond Index (EMBI)?
Loan against MFs: Opt if portfolio growth set to outpace loan rate
Business Standard India· 2 days agoOnly 59 per cent of the equity investments owned by retail investors are held for more than 24...
Sensex @80K: 3 things investors must do now
CNBC Awaaz· 8 hours agoEquity markets have yet again climbed another peak. This time, the S&P BSE Sensex crossed the 80,000-point mark on July 3 -- for the first time. Here are...
Emcure Pharma IPO Day 2: Issue subscribed 2x; NIIs lead from the front
CNBC Awaaz· 12 hours agoBrokerages have positively viewed Emcure Pharma's IPO, considering the public offer fairly priced...
Stocks in news: Vodafone, Tata Steel, UltraTech, GAIL, HDFC Life, TVS Motor and Bank of Baroda
Business Today· 4 days agoStocks including Vodafone, Tata Steel, UltraTech, GAIL, HDFC Life, TVS Motor, Godrej Properties,...
G-Secs win entry to JP Morgan index, inclusion to potentially lead to $22 billion inflows
The Telegraph· 6 days agoIndian government bonds (G-Secs) have officially joined JP Morgan’s Government Bond Index-Emerging...
Emcure Pharma IPO: Issue subscribed 29% on Day 1 so far; NIIs lead from the front
CNBC Awaaz· 1 day agoA day before the drugmaker's public offer went live, Emcure Pharmaceuticals raised Rs 582.6 crore...
Emcure Pharmaceuticals Raises Rs 582.6 Crore from Institutional Investors | India Infoline
India Infoline· 2 days agoPune-based Emcure Pharmaceuticals raises Rs 582.6 crore from institutional investors through an anchor book.